Tandem Diabetes Care Inc (TNDM)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$18.10

Buy

$18.13

arrow-down$-0.50 (-2.69%)

Prices updated at 03 Jun 2026, 17:49 EDT

Prices minimum 15 mins delay

Prices in USD

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm ...

NASDAQ

-0.99%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Ms. Rebecca B. Robertson

CEO

Mr. John F. Sheridan

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

2,500

Head office

12400 High Bluff Drive

San Diego

United States

92130

+1 858 366-6900

smorrison@tandemdiabetes.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Christopher J. Twomey Independent Director	0.08m
Mr. John F. Sheridan Director, President and Chief Executive Officer	0.79m
Mr. Rick Carpenter Executive Vice President and Chief Technology Officer	-
Ms. Peyton R. Howell Independent Director	0.08m
Ms. Susan Morrison Executive Vice President and Chief Administrative Officer	-
Mr. Rajwant S. Sodhi Independent Director	0.08m
Ms. Leigh A. Vosseller Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer	0.49m
Ms. Rebecca B. Robertson Chairman of the Board	0.13m
Ms. Elizabeth A. Gasser Executive Vice President and Chief Strategy and Product Officer	0.46m
Mr. Jean-Claude Kyrillos Executive Vice President and Chief Operating Officer	-
Dr. Kathleen McGroddy-Goetz, PhD Independent Director	0.08m
Ms. Shannon Marie Hansen Executive Vice President, Chief Legal, Privacy and Compliance Officer and Secretary	0.46m
Mr. Myoungil Cha Independent Director	0.07m
Mr. Joao Paulo Falcao Malagueira Independent Director	0.07m
Ms. Sandra Beaver Independent Director	0.00m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	10,690,844
BlackRock Fund Advisors	7,419,117
Vanguard Group Inc	7,341,356
Sessa Capital, L.P	4,730,757
iShares Core S&P Small-Cap ETF	4,110,057

Director dealings

Date chevron-l-regular chevron-r-regular	Action
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
15 Dec 2025	-
04 Dec 2025	-
04 Dec 2025	-
17 Nov 2025	-
17 Nov 2025	-
17 Nov 2025	-
17 Nov 2025	-
17 Nov 2025	-
17 Nov 2025	-
17 Nov 2025	-
17 Nov 2025	-
17 Nov 2025	-
17 Nov 2025	-
17 Nov 2025	-
17 Nov 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.